Gunpo, South Korea

Kwang Il Shin

This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Lotte Fine Chemical Co., Ltd.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kwang Il Shin. Retrieved from https://idiyas.com/inventor/kwang-il-shin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kwang Il Shin: Innovator in Oral Tablet Composition

Introduction

Kwang Il Shin is a notable inventor based in Gunpo-si, South Korea. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of oral tablet compositions.

Latest Patents

Kwang Il Shin holds a patent for an oral tablet composition comprising dexlansoprazole. This invention includes an oral tablet composition that features amorphous dexlansoprazole, mannitol with an average particle size of 100 to 400 micrometers, a disintegrating agent, and a lubricant. The oral tablet composition exhibits excellent hardness and a shortened disintegration time, while also providing improved friability. The manufacturing method utilizes a dry direct compression technique, enhancing production efficiency by simplifying the production process.

Career Highlights

Kwang Il Shin is associated with Lotte Fine Chemical Co., Ltd., where he applies his expertise in pharmaceutical innovations. His work has contributed to advancements in the formulation of oral medications, benefiting both manufacturers and patients.

Collaborations

He has collaborated with notable colleagues, including Kyung Yeol Park and Sang Youb Lee, to further enhance the development of innovative pharmaceutical products.

Conclusion

Kwang Il Shin's contributions to the field of oral tablet compositions demonstrate his commitment to innovation in pharmaceuticals. His work not only improves the efficiency of production processes but also enhances the quality of oral medications available to consumers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…